Quick Answer
Pasithea Therapeutics Corp. reported Total Revenue of $486.6 thousand for fiscal year 2022.
Pasithea Therapeutics Corp. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2022 | $486.6K | +3130.4% |
| 2021 | $15.1K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $218.6K | — | +1509.7% |
| June 30, 2022 | $13.6K | — | -0.6% |
| March 31, 2022 | $13.7K | — | — |
- Pasithea Therapeutics Corp. showed an increase of +3130.4% in Total Revenue compared to the prior fiscal year.
- Over the 2021–2022 period, Pasithea Therapeutics Corp.’s total revenue has grown by 3130.4% (from $15.1 thousand to $486.6 thousand).
- The most recent figure is from Pasithea Therapeutics Corp.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 30, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: